Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Advanced-stage syphilis unmasking after immunomodulator therapy in a patient with ulcerative colitis.
Bettenworth D, Floer M, Krummenerl T, Wehrmann W, Schärer L, Heidemann J.
Am J Gastroenterol. 2012 Jan;107(1):144-5. doi: 10.1038/ajg.2011.330. No abstract available.
Related citations
Editorial: bugs and drugs: insights into the pathogenesis of inflammatory bowel disease.
Nguyen GC.
Am J Gastroenterol. 2011 Dec;106(12):2143-5. doi: 10.1038/ajg.2011.308.
Potential use of telemedicine to provide outpatient care for inflammatory bowel disease.
Krier M, Kaltenbach T, McQuaid K, Soetikno R.
Am J Gastroenterol. 2011 Dec;106(12):2063-7. doi: 10.1038/ajg.2011.329.
Treatment of hospitalized adult patients with severe ulcerative colitis: Toronto consensus statements.
Bitton A, Buie D, Enns R, Feagan BG, Jones JL, Marshall JK, Whittaker S, Griffiths AM, Panaccione R; Canadian Association of Gastroenterology Severe Ulcerative Colitis Consensus Group.
Am J Gastroenterol. 2012 Feb;107(2):179-94; author reply 195. doi: 10.1038/ajg.2011.386. Epub 2011 Nov 22.
Efficacy of oral vs. topical, or combined oral and topical 5-aminosalicylates, in Ulcerative Colitis: systematic review and meta-analysis.
Ford AC, Khan KJ, Achkar JP, Moayyedi P.
Am J Gastroenterol. 2012 Feb;107(2):167-76; author reply 177. doi: 10.1038/ajg.2011.410. Epub 2011 Nov 22. Review.
Risk factors for cardiovascular events in inflammatory bowel disease.
Raftery T, O'Sullivan M.
Am J Gastroenterol. 2011 Nov;106(11):2042; author reply 2042-3. doi: 10.1038/ajg.2011.261. No abstract available.
Biologics in fistulizing Crohn's disease: so near, yet so far.
Atreja A, Bahuva R, Sands BE.
Am J Gastroenterol. 2011 Nov;106(11):2045-6; author reply 2046. doi: 10.1038/ajg.2011.273. No abstract available.
Importance of rare and private NOD2 variants in foreseeing severe disease behavior in Crohn's disease.
Büning C, Prager M, Büttner J.
Am J Gastroenterol. 2011 Nov;106(11):2044-5; author reply 2045. doi: 10.1038/ajg.2011.262. No abstract available.
When meta-analysis misleads.
Yang M, Robinson AM, Pollack PF.
Am J Gastroenterol. 2011 Nov;106(11):2043; author reply 2044. doi: 10.1038/ajg.2011.245. No abstract available.
Supplementation with oral vs. intravenous iron for anemia with IBD or gastrointestinal bleeding: is oral iron getting a bad rap?
Rizvi S, Schoen RE.
Am J Gastroenterol. 2011 Nov;106(11):1872-9. doi: 10.1038/ajg.2011.232. Review.
Strategies for the prevention of postoperative recurrence in Crohn's disease: results of a decision analysis.
Ananthakrishnan AN, Hur C, Juillerat P, Korzenik JR.
Am J Gastroenterol. 2011 Nov;106(11):2009-17. doi: 10.1038/ajg.2011.237. Epub 2011 Jul 26.
Role of thiopurine and anti-TNF therapy in lymphoma in inflammatory bowel disease.
Herrinton LJ, Liu L, Weng X, Lewis JD, Hutfless S, Allison JE.
Am J Gastroenterol. 2011 Dec;106(12):2146-53. doi: 10.1038/ajg.2011.283. Epub 2011 Oct 25.
Splenic littoral cell hemangioendothelioma in a patient with Crohn's disease previously treated with immunomodulators and anti-TNF agents: a rare tumor linked to deep immunosuppression.
Cappello M, Bravatà I, Cocorullo G, Cacciatore M, Florena AM.
Am J Gastroenterol. 2011 Oct;106(10):1863-5. doi: 10.1038/ajg.2011.204. No abstract available.
Efficacy of 5-aminosalicylates for the maintenance of remission in Crohn's disease.
Akobeng AK.
Am J Gastroenterol. 2011 Oct;106(10):1857; author reply 1857-8. doi: 10.1038/ajg.2011.217. No abstract available.
Association between the use of antibiotics and new diagnoses of Crohn's disease and ulcerative colitis.
Shaw SY, Blanchard JF, Bernstein CN.
Am J Gastroenterol. 2011 Dec;106(12):2133-42. doi: 10.1038/ajg.2011.304. Epub 2011 Sep 13.
Once-daily dosing vs. conventional dosing schedule of mesalamine and relapse of quiescent ulcerative colitis: systematic review and meta-analysis.
Ford AC, Khan KJ, Sandborn WJ, Kane SV, Moayyedi P.
Am J Gastroenterol. 2011 Dec;106(12):2070-7; quiz 2078. doi: 10.1038/ajg.2011.296. Epub 2011 Sep 6. Review.
HIV testing: a must for patients with inflammatory bowel disease?
Soria A, Rossi M, Muscatello A, Gori A.
Am J Gastroenterol. 2011 Sep;106(9):1727-8. doi: 10.1038/ajg.2011.186. No abstract available.
Role of 5-aminosalicylate in preventing colorectal cancer.
Riyaz S, Hamlin J, Everett S.
Am J Gastroenterol. 2011 Sep;106(9):1720-1; author reply 1721-2. doi: 10.1038/ajg.2011.205. No abstract available.
The London position statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: safety.
Van Assche G, Lewis JD, Lichtenstein GR, Loftus EV, Ouyang Q, Panes J, Siegel CA, Sandborn WJ, Travis SP, Colombel JF.
Am J Gastroenterol. 2011 Sep;106(9):1594-602; quiz 1593, 1603. doi: 10.1038/ajg.2011.211. Epub 2011 Aug 16. Review.
Increased risks of developing anxiety and depression in young patients with Crohn's disease.
Loftus EV Jr, Guérin A, Yu AP, Wu EQ, Yang M, Chao J, Mulani PM.
Am J Gastroenterol. 2011 Sep;106(9):1670-7. doi: 10.1038/ajg.2011.142. Epub 2011 May 3.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on